Vinson & Elkins advised Lexicon Pharmaceuticals, while Simpson Thacher represented Invus on the deal. Cooley represented the underwriters for the public offering. Lexicon Pharmaceuticals, Inc. (Nasdaq:...
Lexicon Pharmaceuticals’ $143.7 Million Common Stock Offering
Lexicon Pharmaceuticals’ $42.9 Million Private Placement
Simpson Thacher represented Invus on the deal. Lexicon has agreed to sell 17,156,400 shares of its Common Stock to raise gross proceeds of approximately $42.9 million...